1. Home
  2. LFCR vs IIF Comparison

LFCR vs IIF Comparison

Compare LFCR & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFCR
  • IIF
  • Stock Information
  • Founded
  • LFCR 1986
  • IIF 1993
  • Country
  • LFCR United States
  • IIF United States
  • Employees
  • LFCR N/A
  • IIF N/A
  • Industry
  • LFCR Biotechnology: Pharmaceutical Preparations
  • IIF Trusts Except Educational Religious and Charitable
  • Sector
  • LFCR Health Care
  • IIF Finance
  • Exchange
  • LFCR Nasdaq
  • IIF Nasdaq
  • Market Cap
  • LFCR 308.8M
  • IIF 270.7M
  • IPO Year
  • LFCR N/A
  • IIF N/A
  • Fundamental
  • Price
  • LFCR $7.37
  • IIF $27.02
  • Analyst Decision
  • LFCR Buy
  • IIF
  • Analyst Count
  • LFCR 4
  • IIF 0
  • Target Price
  • LFCR $8.00
  • IIF N/A
  • AVG Volume (30 Days)
  • LFCR 125.1K
  • IIF 45.4K
  • Earning Date
  • LFCR 08-07-2025
  • IIF 01-01-0001
  • Dividend Yield
  • LFCR N/A
  • IIF 13.94%
  • EPS Growth
  • LFCR N/A
  • IIF N/A
  • EPS
  • LFCR N/A
  • IIF N/A
  • Revenue
  • LFCR $128,867,000.00
  • IIF N/A
  • Revenue This Year
  • LFCR $4.10
  • IIF N/A
  • Revenue Next Year
  • LFCR $14.29
  • IIF N/A
  • P/E Ratio
  • LFCR N/A
  • IIF N/A
  • Revenue Growth
  • LFCR 0.47
  • IIF N/A
  • 52 Week Low
  • LFCR $3.68
  • IIF $18.95
  • 52 Week High
  • LFCR $8.85
  • IIF $24.41
  • Technical
  • Relative Strength Index (RSI)
  • LFCR 47.91
  • IIF 46.36
  • Support Level
  • LFCR $7.03
  • IIF $26.66
  • Resistance Level
  • LFCR $7.87
  • IIF $26.98
  • Average True Range (ATR)
  • LFCR 0.40
  • IIF 0.26
  • MACD
  • LFCR 0.01
  • IIF -0.02
  • Stochastic Oscillator
  • LFCR 53.70
  • IIF 42.53

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

About IIF Morgan Stanley India Investment Fund Inc.

Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.

Share on Social Networks: